Johanna Dalmo - Publications

A validation protocol for177Lu-SPECT image quantification as a basis for multi-centre kidney dosimetry.

Journal: Physics in medicine and biology

Published: November 21, 2024

Traceable calibration with 177Lu and comparison of activity meters at hospitals in Norway and Sweden.

Journal: Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)

Published: July 17, 2023

THE POTENTIAL TO USE TLD MEASUREMENTS TO VALIDATE THE OCCUPATIONAL RADIATION PROTECTION AT THE DEPARTMENT OF NUCLEAR MEDICINE.

Journal: Radiation protection dosimetry

Published: October 30, 2020

Transcriptional effects of 177Lu-octreotate therapy using a priming treatment schedule on GOT1 tumor in nude mice.

Journal: EJNMMI research

Published: December 06, 2018

Time-dependent transcriptional response of GOT1 human small intestine neuroendocrine tumor after 177Lu[Lu]-octreotate therapy.

Journal: Nuclear medicine and biology

Published: July 14, 2017

Priming increases the anti-tumor effect and therapeutic window of 177Lu-octreotate in nude mice bearing human small intestine neuroendocrine tumor GOT1.

Journal: EJNMMI research

Published: June 23, 2016

Evaluation of retinol binding protein 4 and carbamoylated haemoglobin as potential renal toxicity biomarkers in adult mice treated with (177)Lu-octreotate.

Journal: EJNMMI research

Published: July 19, 2014

Gastrointestinal stromal tumors (GISTs) express somatostatin receptors and bind radiolabeled somatostatin analogs.

Journal: Acta oncologica (Stockholm, Sweden)

Published: November 03, 2012

Specific binding and uptake of 131I-MIBG and 111In-octreotide in metastatic paraganglioma--tools for choice of radionuclide therapy.

Journal: Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme

Published: May 09, 2012

Biodistribution of 177Lu-octreotate and 111In-minigastrin in female nude mice transplanted with human medullary thyroid carcinoma GOT2.

Journal: Oncology reports

Published: July 25, 2011